Wondering... do oncologists consider KRAS a "driver" oncogene or a "passenger" oncogene in colorectal cancer? “Regarding CRC, although #KRAS mutations occur as an early event in about 50% of cases, they are probably not the primary initiating events..." h
1,505 followers
520 followers
RT @JournalofExper1: Best of JECCR 2018 ⬇️ 🧐 𝐓𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠 𝐊𝐑𝐀𝐒 𝐢𝐧 𝐦𝐞𝐭𝐚𝐬𝐭𝐚𝐭𝐢𝐜 𝐜𝐨𝐥𝐨𝐫𝐞𝐜𝐭𝐚𝐥 𝐜𝐚𝐧𝐜𝐞𝐫 #PatientDerivedXenograft (PDXs) #KRASmRNA #Ep…
520 followers
Best of JECCR 2018 ⬇️ 🧐 𝐓𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠 𝐊𝐑𝐀𝐒 𝐢𝐧 𝐦𝐞𝐭𝐚𝐬𝐭𝐚𝐭𝐢𝐜 𝐜𝐨𝐥𝐨𝐫𝐞𝐜𝐭𝐚𝐥 𝐜𝐚𝐧𝐜𝐞𝐫 #PatientDerivedXenograft (PDXs) #KRASmRNA #EpidermalGrowthFactorReceptor (EGFR) See here 👇 https://t.co/B00w7u8cW2 https://t.co/k0heTpzjuZ